Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Islet β cell failure in type 2 diabetes
Marc Prentki, Christopher J. Nolan
Marc Prentki, Christopher J. Nolan
Published July 3, 2006
Citation Information: J Clin Invest. 2006;116(7):1802-1812. https://doi.org/10.1172/JCI29103.
View: Text | PDF
Review Series Article has an altmetric score of 31

Islet β cell failure in type 2 diabetes

  • Text
  • PDF
Abstract

The major focus of this Review is on the mechanisms of islet β cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of β cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of β cell mass and for enhanced β cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of “susceptible” islets and overall risk for T2D is reviewed. The likely mechanisms of β cell failure are discussed within the two broad categories: those with initiation and those with progression roles.

Authors

Marc Prentki, Christopher J. Nolan

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 12 25 35 40 55 51 50 40 50 59 48 59 44 49 40 33 30 26 7 2 755
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2023 (35)

Title and authors Publication Year
Hypoxia causes pancreatic β-cell dysfunction by activating a transcriptional repressor BHLHE40
Tomonori Tsuyama, Yoshifumi Sato, Tatsuya Yoshizawa, Takaaki Matsuoka, Kazuya Yamagata
EMBO reports 2023
TRPM7 kinase is required for insulin production and compensatory islet responses during obesity
Noushafarin Khajavi, Andreas Beck, Klea Ricku, Philipp Beyerle, Katharina Jacob, Sabrina Syamsul, Anouar Belkacemi, Houssein Salah, Tanja Popp, Aaron Novikoff, Andreas Breit, Vladimir Chubanov, Timo Müller, Susanna Zierler, Thomas Gudermann
JCI Insight 2023
Luteolin-7-O-rutinoside Protects RIN-5F Cells from High-Glucose-Induced Toxicity, Improves Glucose Homeostasis in L6 Myotubes, and Prevents Onset of Type 2 Diabetes.
Subash-Babu P, Abdulaziz AlSedairy S, Abdulaziz Binobead M, Alshatwi AA
Metabolites 2023
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target.
Muehlebach ME, Holstein SA
Clinical and Translational Medicine 2023
No Time to Die—How Islets Meet Their Demise in Transplantation
Kale A, Rogers NM
Cells 2023
β‐Cell glucokinase expression was increased in type 2 diabetes subjects with better glycemic control
Liu J, Fu H, Kang F, Ning G, Ni Q, Wang W, Wang Q
Journal of Diabetes 2023
Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets.
Lorza-Gil E, Kaiser G, Carlein C, Hoffmann MDA, König GM, Haug S, Prates Roma L, Rexen Ulven E, Ulven T, Kostenis E, Birkenfeld AL, Häring HU, Ullrich S, Gerst F
Diabetologia 2023
A highly sensitive strategy for monitoring real-time proliferation of targeted cell types in vivo.
Sugawara H, Imai J, Yamamoto J, Izumi T, Kawana Y, Endo A, Kohata M, Seike J, Kubo H, Komamura H, Munakata Y, Asai Y, Hosaka S, Sawada S, Kodama S, Takahashi K, Kaneko K, Katagiri H
Nature Communications 2023
Prevalence of Type 2 Diabetes, Impaired Fasting Glucose, and Diabetes Risk in an Adult and Older North-Eastern Portuguese Population
Magalhães PM, Teixeira JE, Bragada JP, Duarte CM, Bragada JA
Healthcare 2023
Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells
Xu W, Qadir MM, Nasteska D, de Sa PM, Gorvin CM, Blandino-Rosano M, Evans CR, Ho T, Potapenko E, Veluthakal R, Ashford FB, Bitsi S, Fan J, Bhondeley M, Song K, Sure VN, Sakamuri SS, Schiffer L, Beatty W, Wyatt R, Frigo DE, Liu X, Katakam PV, Arlt W, Buck J, Levin LR, Hu T, Kolls J, Burant CF, Tomas A, Merrins MJ, Thurmond DC, Bernal-Mizrachi E, Hodson DJ, Mauvais-Jarvis F
Cell Reports 2023
Erigeron annuus Extract Alleviates Insulin Resistance via Regulating the Expression of Mitochondrial Damage and Endoplasmic Reticulum Stress-Related Genes
Lee HK, Nam YH, Shin SW, Kim MC, An JI, Kim NW, Shim JH, Srinath S, Hong BN, Kwak JH, Kang TH
Nutrients 2023
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes
Soldovieri L, Di Giuseppe G, Ciccarelli G, Quero G, Cinti F, Brunetti M, Nista EC, Gasbarrini A, Alfieri S, Pontecorvi A, Giaccari A, Mezza T
Molecular Metabolism 2023
Regeneration of Pancreatic Beta Cells by Modulation of Molecular Targets Using Plant-Derived Compounds: Pharmacological Mechanisms and Clinical Potential.
Kimani CN, Reuter H, Kotzé SH, Muller CJF
Current issues in molecular biology 2023
RESTORING CONNEXIN-36 FUNCTION IN DIABETOGENIC ENVIRONMENTS PRECLUDES MOUSE AND HUMAN ISLET DYSFUNCTION
St. Clair JR, Westacott MJ, Miranda J, Farnsworth NL, Kravets V, Schleicher WE, Dwulet JM, Levitt CH, Heintz A, Ludin NW, Benninger RK
The Journal of Physiology 2023
The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
Kim J, Oh CM, Kim H
Biomedicines 2023
Leucine suppresses glucagon secretion from pancreatic islets by directly modulating α-cell cAMP.
Knuth ER, Foster HR, Jin E, Merrins MJ
bioRxiv : the preprint server for biology 2023
Optimizing diabetic kidney disease animal models: Insights from a meta-analytic approach.
Li F, Ma Z, Cai Y, Zhou J, Liu R
2023
Beta-cell compensation and gestational diabetes
Usman TO, Chhetri G, Yeh H, Dong HH
The Journal of biological chemistry 2023
Endoplasmic Reticulum Stress and Its Impact on Adipogenesis: Molecular Mechanisms Implicated
Kim G, Lee J, Ha J, Kang I, Choe W
Nutrients 2023
Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review
Xie X, Wu C, Hao Y, Wang T, Yang Y, Cai P, Zhang Y, Huang J, Deng K, Yan D, Lin H
Frontiers in Endocrinology 2023
Slc12a2 loss in insulin-secreting β-cells links development of overweight and metabolic dysregulation to impaired satiation control of feeding
Rathod YD, Abdelgawad R, Hübner CA, Di Fulvio M
American journal of physiology. Endocrinology and metabolism 2023
Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes
Rashid M, Al Qarni A, Al Mahri S, Mohammad S, Khan A, Abdullah ML, Lehe C, Al Amoudi R, Aldibasi O, Bouchama A
Journal of the Endocrine Society 2023
Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications
Yanai H, Adachi H, Hakoshima M, Katsuyama H
Biology 2023
The Role of Gut Microbiota in High-Fat-Diet-Induced Diabetes: Lessons from Animal Models and Humans
Qi Y, Wang X
Nutrients 2023
Knowledge domain and emerging trends in beta‐cell research: A bibliometric and knowledge‐map analysis
Luo Y, Wang T, Chen Z, Zhang G
Frontiers in Endocrinology 2023
Editorial: Study of pancreatic islets based on human models to understand pathogenesis of diabetes
Imai Y, Soleimanpour SA, Tessem JS
Frontiers in Endocrinology 2023
Metabolic Characteristics of Gestational Diabetes Mellitus and the Effects on Pregnancy Outcomes
Luo P, Fan Y, Xiong Y, Zhang C, Yang Z, Sun F, Mei B
2023
Comparative Evaluation of Adipokine Metrics for the Diagnosis of Gestational Diabetes Mellitus.
Kamiński M, Mierzyński R, Poniedziałek-Czajkowska E, Sadowska A, Sotowski M, Leszczyńska-Gorzelak B
International journal of molecular sciences 2023
Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight.
Chakraborty S, Verma A, Garg R, Singh J, Verma H
Clinical Medicine Insights. Endocrinology and Diabetes 2023
Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes.
Meeks KAC, Bentley AR, Assimes TL, Franceschini N, Adeyemo AA, Rotimi CN, Doumatey AP
Genome Medicine 2023
Editorial: Pharmacological and non-pharmacological therapy for obesity and diabetes - volume II.
Oliveira AG, Carvalho BM, Zweig Rocha G
Frontiers in Endocrinology 2023
Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment.
Ivić V, Zjalić M, Blažetić S, Fenrich M, Labak I, Scitovski R, Szűcs KF, Ducza E, Tábi T, Bagamery F, Szökő É, Vuković R, Rončević A, Mandić D, Debeljak Ž, Berecki M, Balog M, Seres-Bokor A, Sztojkov-Ivanov A, Hajagos-Tóth J, Gajović S, Imširović A, Bakula M, Mahiiovych S, Gaspar R, Vari SG, Heffer M
Frontiers in Endocrinology 2023
Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes.
Patra D, Banerjee D, Ramprasad P, Roy S, Pal D, Dasgupta S
Frontiers in Molecular Biosciences 2023
Growth differentiation factor‑15 in patients with gestational diabetes mellitus and its relationship with microalbuminuria.
Gong Y, Shi J, Li J, Liu L
Experimental and therapeutic medicine 2023
Moderate-intensity endurance training improves late phase β-cell function in adults with type 2 diabetes.
Zhang H, Simpson LK, Carbone NP, Hirshman MF, Nigro P, Vamvini M, Goodyear LJ, Middelbeek RJW
iScience 2023

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Blogged by 1
Posted by 1 X users
Referenced in 46 patents
1027 readers on Mendeley
See more details